Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $84.4B |
| FY2017, ended Dec 31, 2017 | $105B |
| FY2018, ended Dec 31, 2018 | $99.9B |
| FY2019, ended Dec 31, 2019 | $125B |
| FY2020, ended Dec 31, 2020 | $139B |
| FY2021, ended Dec 31, 2021 | $160B |
| FY2022, ended Dec 31, 2022 | $127B |
| FY2023, ended Dec 31, 2023 | $150B |
| FY2024, ended Dec 31, 2024 | $138B |
| FY2025, ended Dec 31, 2025 | $137B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $162B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $19.9B |
| FY2017, ended Dec 31, 2017 | $21.2B |
| FY2018, ended Dec 31, 2018 | $22.8B |
| FY2019, ended Dec 31, 2019 | $21.7B |
| FY2020, ended Dec 31, 2020 | $19.5B |
| FY2021, ended Dec 31, 2021 | $21.8B |
| FY2022, ended Dec 31, 2022 | $24.9B |
| FY2023, ended Dec 31, 2023 | $24.1B |
| FY2024, ended Dec 31, 2024 | $24.3B |
| FY2025, ended Dec 31, 2025 | $24.5B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $26.4B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $4.23B | $4.02B |
| FY2017, ended Dec 31, 2017 | $10.7B | $3.99B |
| FY2018, ended Dec 31, 2018 | $5.97B | $5.25B |
| FY2019, ended Dec 31, 2019 | $5.92B | $5.16B |
| FY2020, ended Dec 31, 2020 | $5.35B | $5.61B |
| FY2021, ended Dec 31, 2021 | $6.52B | $6.10B |
| FY2022, ended Dec 31, 2022 | $7.00B | $5.74B |
| FY2023, ended Dec 31, 2023 | $6.38B | $4.77B |
| FY2024, ended Dec 31, 2024 | $6.75B | $5.89B |
| FY2025, ended Dec 31, 2025 | $7.14B | $5.50B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $7.62B | $6.69B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.28B |
| FY2017, ended Dec 31, 2017 | $1.27B |
| FY2018, ended Dec 31, 2018 | $1.27B |
| FY2019, ended Dec 31, 2019 | $831M |
| FY2020, ended Dec 31, 2020 | $1.80B |
| FY2021, ended Dec 31, 2021 | $960M |
| FY2022, ended Dec 31, 2022 | $973M |
| FY2023, ended Dec 31, 2023 | $1.05B |
| FY2024, ended Dec 31, 2024 | $1.02B |
| FY2025, ended Dec 31, 2025 | $1.27B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $2.21B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $15.0B |
| FY2017, ended Dec 31, 2017 | $16.9B |
| FY2018, ended Dec 31, 2018 | $22.6B |
| FY2019, ended Dec 31, 2019 | $25.4B |
| FY2020, ended Dec 31, 2020 | $26.8B |
| FY2021, ended Dec 31, 2021 | $30.1B |
| FY2022, ended Dec 31, 2022 | $33.5B |
| FY2023, ended Dec 31, 2023 | $32.6B |
| FY2024, ended Dec 31, 2024 | $31.2B |
| FY2025, ended Dec 31, 2025 | $31.8B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $30.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 27.0% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 814M |
| FY2017, ended Dec 31, 2017 | 779M |
| FY2018, ended Dec 31, 2018 | 723M |
| FY2019, ended Dec 31, 2019 | 690M |
| FY2020, ended Dec 31, 2020 | 670M |
| FY2021, ended Dec 31, 2021 | 637M |
| FY2022, ended Dec 31, 2022 | 612M |
| FY2023, ended Dec 31, 2023 | 610M |
| FY2024, ended Dec 31, 2024 | 604M |
| FY2025, ended Dec 31, 2025 | 593M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 594M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.10B | $82.0M |
| FY2017, ended Dec 31, 2017 | $4.01B | $103M |
| FY2018, ended Dec 31, 2018 | $8.22B | $96.0M |
| FY2019, ended Dec 31, 2019 | $5.80B | $93.0M |
| FY2020, ended Dec 31, 2020 | $3.71B | $73.0M |
| FY2021, ended Dec 31, 2021 | $7.29B | $88.0M |
| FY2022, ended Dec 31, 2022 | $6.28B | $99.0M |
| FY2023, ended Dec 31, 2023 | $705M | $107M |
| FY2024, ended Dec 31, 2024 | $1.50B | $118M |
| FY2025, ended Dec 31, 2025 | $2.68B | $142M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $26.0M | $130M |
Valuation
At current price- Market Cap
- $178B
- P/E
- 23.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.8×
- Price / Book
- 8.1×
- EV / EBITDA
- 15.7×
Growth
Trailing 12 months- Revenue (TTM)
- $26.4B
- Revenue Growth YoY
- 7.4%
- Revenue CAGR 3Y
- −0.5%
- Revenue CAGR 5Y
- 4.6%
- EPS Growth YoY
- 8.8%
- Net Income Growth YoY
- 8.0%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 40.1%
- Net Margin
- 28.9%
- FCF Margin
- 25.4%
- Return on Equity
- 38.7%
Earnings
Trailing 12 months- Net Income
- $7.62B
- EPS (diluted)
- $12.82
- EBITDA
- $13.1B
- Operating Income
- $10.6B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $2.21B
- Total Debt
- $30.3B
- Net Debt
- $28.1B
- Total Assets
- $72.6B
- Total Liabilities
- $50.6B
- Shareholders' Equity
- $22.0B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $10.5B
- Capital Expenditure
- $3.83B
- Free Cash Flow
- $6.69B
Dividends and risk
Last 12 months- Dividend Yield
- 1.9%
- Dividend / Share
- $5.56
- Beta (5Y)
- 0.95
Every ratio is calculated from the company’s reported figures.